Takashi Kanda

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 800 citations

Medicine, Pharmacology, Pharmacotherapy +6

A perfused human blood–brain barrier on-a-chip for high-throughput assessment of barrier function and antibody transport

Nienke R. Wevers, Dhanesh G. Kasi, Taylor Gray et al. · Fluids and Barriers of the CNS · 2018 · 344 citations · Full text

Engineering, Bioengineering, Biomedical Engineering +17

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial

Ivo N. van Schaik, Vera Bril, Nan van Geloven et al. · The Lancet Neurology · 2017 · 269 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +11

Preparation of Highly Dispersed Core/Shell-type Titania Nanocapsules Containing a Single Ag Nanoparticle

Hideki Sakai, Takashi Kanda, Hirobumi Shibata et al. · Journal of the American Chemical Society · 2006 · 205 citations

Natural Sciences, Chemistry, Materials Science +17

Effects of neuromyelitis optica–IgG at the blood–brain barrier in vitro

Yukio Takeshita, Birgit Obermeier, Anne C. Cotleur et al. · Neurology Neuroimmunology & Neuroinflammation · 2016 · 185 citations · Full text

Life Sciences, Neurology, Neuroscience +17